ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 37 filers reported holding ARGOS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,000 | -50.0% | 11,900 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | -50.0% | 11,900 | 0.0% | 0.00% | – |
Q2 2017 | $4,000 | -95.1% | 11,900 | -93.5% | 0.00% | – |
Q1 2017 | $82,000 | -90.6% | 184,194 | +3.8% | 0.00% | – |
Q4 2016 | $870,000 | +10.5% | 177,494 | +11.7% | 0.00% | – |
Q3 2016 | $787,000 | +6.2% | 158,869 | +31.3% | 0.00% | – |
Q2 2016 | $741,000 | +179.6% | 120,996 | +356.5% | 0.00% | – |
Q1 2014 | $265,000 | – | 26,507 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SANDERS MORRIS HARRIS LLC | 241,512 | $1,201,000 | 0.36% |
WALL STREET ASSOCIATES | 185,097 | $920,000 | 0.31% |
WASATCH ADVISORS LP | 3,228,741 | $16,047,000 | 0.24% |
ALTRINSIC GLOBAL ADVISORS LLC | 172,505 | $857,000 | 0.03% |
Dynamic Technology Lab Private Ltd | 19,007 | $94,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 121,524 | $604,000 | 0.01% |
Alyeska Investment Group, L.P. | 200,000 | $994,000 | 0.01% |
Acrospire Investment Management LLC | 2,100 | $10,000 | 0.01% |
Alyeska Investment Group, L.P. | 111,424 | $554,000 | 0.01% |
Advisor Group, Inc. | 13,500 | $67,000 | 0.00% |